entinostat
Entinostat is a drug used to treat Breast Cancer, Recurrent Adult Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, and other conditions. Entinostat is being actively studied in 19 studies and prior, has been studied in 25.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| National Cancer Institute (NCI) | Johns Hopkins University/Sidney Kimmel Cancer Center | Roberto Pili |
| Syndax Pharmaceuticals | Roswell Park Cancer Institute | Antonio Fojo |
| Roberto Pili | Memorial Sloan Kettering Cancer Center | Fatima Karzai, M.D. |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
- Neuroendocrine Tumors
- Entinostat
- New York, New YorkColumbia University Medical Center
2021-10-06
Oct 6, 2021S
Completed
- Metastatic Cholangiocarcinoma
- +5 more
- Entinostat
- Nivolumab
- Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
2021-12-17
Dec 17, 2021S
Completed
- Breast Cancer
- Estrogen Receptor Positive Breast Cancer
- entinostat
- exemestane
- Denver, Colorado
- +2 more
2021-12-14
Dec 14, 2021S
Completed
- Lung Cancer
- +3 more
- entinostat
- +2 more
- Sarasota, Florida
- +2 more
2021-11-11
Nov 11, 2021R
Active, not recruiting
- Renal Cell Carcinoma
- Entinostat
- +2 more
- Washington, District of Columbia
- +1 more
2022-01-10
Jan 10, 2022R
Suspended
- Metastatic Cancer
- Renal Cancer
- Atezolizumab
- +2 more
- Indianapolis, Indiana
- +3 more
2022-02-25
Feb 25, 2022N
Recruiting
- Cancer
- +3 more
- Bintrafusp Alfa
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022U
Recruiting
- Melanoma
- Entinostat
- Pembrolizumab
- Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
2021-05-08
May 8, 2021G
Terminated
- Prostate Adenocarcinoma
- Entinostat
- Enzalutamide
- Washington, District of ColumbiaGeorge Washington University - Medical Faculty Associates
2021-07-26
Jul 26, 2021R
Active, not recruiting
- Renal Cell Carcinoma
- Entinostat
- Interleukin-2
- Los Angeles, California
- +4 more
2022-02-14
Feb 14, 2022A
Withdrawn
- Pancreas Cancer
- Entinostat
- FOLFOX regimen
- (no location specified)
2021-01-13
Jan 13, 2021N
Not yet recruiting
- Advanced Lymphoma
- +13 more
- BET Bromodomain Inhibitor ZEN-3694
- +2 more
- (no location specified)
2022-03-30
Mar 30, 2022A
Completed
- Colorectal Cancer
- hydroxychloroquine
- +2 more
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2020-12-16
Dec 16, 2020M
V
Terminated
- Fallopian Tube Cancer
- +12 more
- Entinostat
- Olaparib
- Kansas City, Kansas
- +1 more
2022-03-23
Mar 23, 2022S
Completed
- Neoplasms
- +13 more
- Entinostat
- Pembrolizumab
- San Antonio, TexasThe START Center for Cancer Care
2022-01-24
Jan 24, 2022U
Terminated
- Breast Cancer
- +2 more
- Entinostat
- Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
2021-03-22
Mar 22, 2021N
Active, not recruiting
- Male Breast Carcinoma
- +4 more
- Azacitidine
- +3 more
- Duarte, California
- +6 more
2021-12-14
Dec 14, 2021T
Active, not recruiting
- Advanced Breast Cancer
- Entinostat
- +2 more
- Beijing, Beijing, ChinaCancer Hospital Chinese Academy Medical Sciences
2021-07-07
Jul 7, 2021U
Recruiting
- Metastatic Breast Cancer
- Breast Cancer
- Entinostat
- Capecitabine
- Rochester, New York
- +1 more
2020-09-11
Sep 11, 2020N
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
- Los Angeles, California
- +3 more
2021-02-09
Feb 9, 2021N
Active, not recruiting
- Myelodysplastic Syndrome
- Entinostat
- Pembrolizumab
- New Haven, Connecticut
- +18 more
2022-04-05
Apr 5, 2022N
Withdrawn
- Advanced Lymphoma
- +16 more
- Entinostat
- Molibresib
- (no location specified)
2020-09-25
Sep 25, 2020U
Recruiting
- Bladder Cancer
- Pembrolizumab
- Entinostat
- Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
2021-12-20
Dec 20, 2021N
Active, not recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +2 more
- Atezolizumab
- +3 more
- New York, New York
- +4 more
2022-01-04
Jan 4, 2022